Dr Reddys Shares News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dr reddys shares. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dr Reddys Shares Today - Breaking & Trending Today

dr reddy's shares: Dr Reddy's shares rise 4% on Q3 PAT jump but brokerages remain unmoved. Here's why

The drug maker on Tuesday reported an 11% year-on-year (YoY) jump in net profit at Rs 1,379 crore for the quarter ended December 31, 2023, as against Rs 1,247 crore a year ago. The company said the net profit was led by new products and base business market share gain in the US, and also new launches and strong volumes in Europe. The Hyderabad-based firm s revenue rose 7% at Rs 7,215 crore as against Rs 6,770 crore crore in the year-ago period. ....

Andhra Pradesh , Motilal Oswal , Kotak Institutional Equities , While Kotak , Dr Reddys Shares , Dr Reddys Share Price , Dr Reddys Stock , Markets News , Dr Reddy S , Dr Reddys Q3 Results , Dr Reddys Laboratories ,

stocks to buy: F&O stocks to buy today: Dr Reddy's among top 3 trading ideas for 3 January 2023

India VIX was down by 0.68% from 14.68 to 14.58 levels in the previous trading session. Volatility was slightly down and has been cooling off from the last four sessions. ....

Ajay Thakkar , Chandan Taparia , Sun Pharma , Head Alternate Research , Supreme Court , Pidilite Industries , Derivatives At Motilal Oswal Financial Services , Aditya Birla Fashion , Gujarat Gas , Adani Ports , Coal India , Zydus Life , Tata Consumer , Senior Vice President , Motilal Oswal Financial Services Limited , Economic Times , Stocks To Buy , Dr Reddy Rsquo S , Divi Rsquo S , Drl Shares , Dr Reddys Shares , Stock Ideas , Markets News ,

Eris buys nine dermatology brands from Dr. Reddy's for ₹275 cr

The deal, to be paid in cash, is expected to be completed on or before March 31. ....

Glenmark Pharma , Dr Reddy Laboratories Ltd On , Life Insurance Corporation Of India , Eris Lifesciences , Eris Oaknet Healthcare , Laboratories Ltd , Life Insurance Corporation , Dr Reddys Shares , Dr Reddys Laboratories Ltd ,

Dr Reddy's to buy Mayne Pharma's US generic portfolio for $105 million

Dr. Reddy s will make an upfront cash payment of $90 million, as well as contingent payments of up to $15 million, inventory consideration, and credits for certain accrued channel liabilities to be determined on the closing date ....

United States , Mayne Pharma , Marc Kikuchi , Chief Executive Officer , North America , Dr Reddy S , Dr Reddys Shares ,

Dr Reddy's lines up Rs 1,000 crore capex for current fiscal year

Dr Reddy s lines up Rs 1,000 crore capex for current fiscal year
SECTIONS
Last Updated: May 24, 2021, 01:04 PM IST
Share
Agencies
The company remains positive about sustaining its growth trends in the current fiscal and beyond, as per a top company official.
INSIGHTS
NSE
Explore Now
NEW DELHI: Drug major Dr Reddy s Laboratories has earmarked a Capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal and beyond, as per a top company official.
The Hyderabad based firm invested about Rs 1,000 crore in the 2020-21 fiscal.
The Capex will be around the same numbers, maybe a bit higher if everything goes through, Dr Reddy s Laboratories CEO Erez Israeli said in an analyst call. ....

United States , Andhra Pradesh , Drug Administration , North America Generics , Stock In News , Drl Shares , Drl Stock Price , Dr Reddys Shares , Dr Reddys Stock Price , Dr Reddy S , ஒன்றுபட்டது மாநிலங்களில் , ஆந்திரா பிரதேஷ் , வடக்கு அமெரிக்கா ஜெநெரிக்ஸ் , ஸ்டாக் இல் செய்தி , டாக்டர் ரேட்திச் பங்குகள் , டாக்டர் சிவப்பு கள் ,